个人简介
The aim of Professor Schumann`s research is to improve diagnostic and treatment of mental disorder through stratified medicine. As Director of the Centre for Population Neuroscience and Stratified Medicine (PONS) at the IoPPN, King`s College London, he has developed a broad scientific network of international collaborators, who coordinate large scale neuroimaging studies in Europe, China, India and the U.S., to combine state of the art clinical neuroscience and epidemiological techniques with expertise in computer science and biostatistics. His general research interests are in etiological and diagnostic stratification of psychiatric disorders to identify neurobehavioural phenotypes, which allow the development of predictive and prognostic biomarkers. His group thus works on the identification of neurobehavioural mechanisms of psychiatric disorders, including addictions. He pursues an interdisciplinary approach, using neuroimaging, functional genetic and epigenetic methods as well as molecular biological and bioinformatic techniques. He coordinates the longitudinal imaging genetics cohort IMAGEN ‘Reinforcement-related behaviour in normal brain function and psychopathology’, and co-coordinates the cVEDA – project, an international Consortium on Vulnerability to Externalizing Disorders and Addictions. He is in the steering group of the imaging meta-analysis consortium ENIGMA and leads the AlcoGen consortium on genetics of alcohol drinking.
Awards and Other Achievements
In recognition of his scientific achievements, the applicant has received several awards at various stages of his career, includinganHumboldt Award,an Advanced Investigator Awardby the European Research Council, anAward of the European College of Neuropharmacology for the best basic research projectand theWilhelm Feuerlein Research Award of the German Addiction Foundation. The applicant was invited to plenary talks at major international congresses, including the European College of Neuropsychopharmacology and the World Congress of Psychiatric Genetics as well as prestigious named lectures, such as the Okey Lecture, and the symposium of the Royal Society on “Neurobiology of Addictions” to present and discuss his research findings. In recognition of his expertise, the applicant was tasked by theEuropean Commissiontolead the development of a Biomedical Research Strategy for a European Roadmap for Mental Health Research. The applicant served asa member of the Scientific Advisory Board of the Leibniz Institute for Neuroscience, Magdeburg and the EU-Innovative Medicine Initiative ‘AETIONOMY’.
京公网安备 11010802027423号